Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Management and Treatment of Stress-related Disorders (INTERSTRESS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Giuseppe Riva, Istituto Auxologico Italiano
ClinicalTrials.gov Identifier:
NCT01683617
First received: September 5, 2012
Last updated: January 31, 2014
Last verified: January 2014
  Purpose

Psychological stress occurs when an individual perceives that environmental demands tax or exceed his or her adaptive capacity. In this view, stressful experiences are conceptualized as person-environment transactions, whose result is dependent on the impact of the external stimulus. This is mediated by the person's appraisal of the significance of the stimulus, of the personal, social and cultural resources available and of the efficacy of the coping efforts.

Extreme levels of stress can have a negative influence on one's professional life and can disrupt both the social and personal life of an individual. Stress can also cause different physiological and psychological disorders such as anxiety, chronic headaches, depression, withdrawal symptoms, nausea, phobias, blood pressure problems, heart impairments and others.

Stress Management Therapy can help to overcome counter effects of stress. Usually various techniques are used including relaxation, interaction, biofeedback and Cognitive Behavior Therapy methods. According to the Cochrane Database of Systematic Reviews the best validated approach covering both stress management and stress treatment is the Cognitive Behavioral Therapy (CBT) approach.

The trouble with stress is that it is very personal. Thus, stress-related disorders depend a great deal on how the person experiencing a stressor is put together —psychologically and physically. So the focus for assessment, prediction and treatment has to be the person's situated experience.

To overcome the above limitations, the INTERSTRESS project suggests the adoption of a new paradigm for e-health - Interreality - that integrates contextualized assessment and treatment within a hybrid environment, bridging physical and virtual world.

From the clinical point of view the INTERSTRESS solution may offer the following innovations to current traditional protocols for stress management:

  • Objective and quantitative assessment of user's stress level using biosensors and behavioral analysis;
  • Provision of warnings and motivating feedbacks to improve self awareness, compliance and long term outcome;
  • Decision Support System (DSS) for treatment planning through data fusion and detection algorithms.

Condition Intervention Phase
Psychological Stress
Behavioral: Coping skills and relaxation training with new technologies
Behavioral: Traditional coping skills and relaxation training
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: INTERSTRESS - Interreality in the Management and Treatment of Stress-related Disorders

Resource links provided by NLM:


Further study details as provided by Istituto Auxologico Italiano:

Primary Outcome Measures:
  • Level of psychological stress measured by psychometric questionnaires (PSM, PSS, COPE, PSQI, SWLS, STAI) [ Time Frame: five weeks ] [ Designated as safety issue: No ]
    Treatment duration is 5 weeks. Outcome measures are assessed before and after treatment and at follow-up (18-month).

  • quality of life [ Time Frame: 5 weeks ] [ Designated as safety issue: No ]
  • psychophysiological measures (heart rate and heart rate variability indexes) [ Time Frame: 5 weeks ] [ Designated as safety issue: No ]

Enrollment: 100
Study Start Date: May 2012
Estimated Study Completion Date: July 2015
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A treatment based on CBT and new technologies
Individuals will receive a treatment based on cognitive behavioral therapy and new technologies (virtual reality, virtual reality combined to biofeedback and mobile phones). Relaxation will be induced through the immersion in different virtual environments (e.g., lake) which will be customized with different pre-recorded audio narratives that describe the specific setting and that guide the execution of a series of relaxation exercises. During biofeedback exercises a wearable biosensor system will provide suggestions to the trainer based on the reactions of the participants, and the biosensor data will directly modify the virtual reality experience in real time.
Behavioral: Coping skills and relaxation training with new technologies
Active Comparator: Traditional treatment based on CBT
Participants will receive a treatment based on traditional cognitive behavioral therapy techniques for stress management, without the use of new technologies. Relaxation will be induced by guided imagery, through auditory narratives.
Behavioral: Traditional coping skills and relaxation training

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   25 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individual who suffer from psychological stress;
  • Age between 25 and 60 years.

Exclusion Criteria:

  • DSM_IV-TR Axis I disorders;
  • history of neurological diseases, mental retardation, psychosis, alcohol or drug dependence;
  • psychotherapy received for their psychological stress;
  • pharmacotherapy received for their psychological stress;
  • migraine, headache, or vestibular abnormalities.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01683617

Locations
Italy
Istituto Auxologico Italiano
Milano, MI, Italy, 20100
Sponsors and Collaborators
Istituto Auxologico Italiano
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Giuseppe Riva, Scientific coordinator, Istituto Auxologico Italiano
ClinicalTrials.gov Identifier: NCT01683617     History of Changes
Other Study ID Numbers: 03E901, FP7-247685
Study First Received: September 5, 2012
Last Updated: January 31, 2014
Health Authority: Italy: Ministry of Health

Keywords provided by Istituto Auxologico Italiano:
Psychological stress

Additional relevant MeSH terms:
Psychophysiologic Disorders
Stress, Psychological
Behavioral Symptoms
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on November 25, 2014